Search by Drug Name or NDC

    NDC 50090-1470-00 Lithium Carbonate 300 mg/1 Details

    Lithium Carbonate 300 mg/1

    Lithium Carbonate is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is LITHIUM CARBONATE.

    Product Information

    NDC 50090-1470
    Product ID 50090-1470_29a6d276-ba80-4bdf-9f0e-c976d7369b33
    Associated GPIs 59500010100405
    GCN Sequence Number 004004
    GCN Sequence Number Description lithium carbonate TABLET ER 300 MG ORAL
    HIC3 H2M
    HIC3 Description BIPOLAR DISORDER DRUGS
    GCN 15731
    HICL Sequence Number 001669
    HICL Sequence Number Description LITHIUM CARBONATE
    Brand/Generic Generic
    Proprietary Name Lithium Carbonate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lithium Carbonate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name LITHIUM CARBONATE
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091544
    Listing Certified Through 2025-12-31

    Package

    NDC 50090-1470-00 (50090147000)

    NDC Package Code 50090-1470-0
    Billing NDC 50090147000
    Package 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-1470-0)
    Marketing Start Date 2014-11-28
    NDC Exclude Flag N
    Pricing Information N/A